# A Study to Learn About the Study Medicine (Called Marstacimab) in People With Hemophilia A or B

> **NCT07859527** · — · NOT_YET_RECRUITING · sponsor: **Pfizer** · enrollment: 100 (estimated)

## Conditions studied

- Hemophilia

## Interventions

- **DRUG:** Marstacimab

## Key facts

- **NCT ID:** NCT07859527
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-10-05
- **Primary completion:** 2028-08-30
- **Final completion:** 2028-08-30
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-10-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07859527

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07859527, "A Study to Learn About the Study Medicine (Called Marstacimab) in People With Hemophilia A or B". Retrieved via MORVS 2026-11-22 from https://api.morvs.ai/clinical/NCT07859527. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
